Literature DB >> 35687272

Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system.

Omar Al-Massadi1,2, Paolo Parini3,4,5, Johan Fernø6, Serge Luquet7, Mar Quiñones8,9,10.   

Abstract

The growth hormone/insulin growth factor-1 axis is a key endocrine system that exerts profound effects on metabolism by its actions on different peripheral tissues but also in the brain. Growth hormone together with insulin growth factor-1 perform metabolic adjustments, including regulation of food intake, energy expenditure, and glycemia. The dysregulation of this hepatic axis leads to different metabolic disorders including obesity, type 2 diabetes or liver disease. In this review, we discuss how the growth hormone/insulin growth factor-1 axis regulates metabolism and its interactions with the central nervous system. Finally, we state our vision for possible therapeutic uses of compounds based in the components of this hepatic axis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Brain; Energy balance; GH; IGF-1; Liver

Mesh:

Substances:

Year:  2022        PMID: 35687272     DOI: 10.1007/s11154-022-09732-x

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   9.306


  100 in total

Review 1.  Metabolic factors in the control of energy stores.

Authors:  G A Bray; L A Campfield
Journal:  Metabolism       Date:  1975-01       Impact factor: 8.694

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

3.  Participation of hepatic glucoreceptors in the control of intake of food.

Authors:  M RUSSEK
Journal:  Nature       Date:  1963-01-05       Impact factor: 49.962

Review 4.  Environmental contributions to the obesity epidemic.

Authors:  J O Hill; J C Peters
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

5.  NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates.

Authors:  Serge Luquet; Francisco A Perez; Thomas S Hnasko; Richard D Palmiter
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

Review 6.  Current status of the hepatostatic theory of food intake control.

Authors:  M Russek
Journal:  Appetite       Date:  1981-06       Impact factor: 3.868

Review 7.  Current Understanding of the Hypothalamic Ghrelin Pathways Inducing Appetite and Adiposity.

Authors:  Omar Al Massadi; Miguel López; Matthias Tschöp; Carlos Diéguez; Ruben Nogueiras
Journal:  Trends Neurosci       Date:  2017-01-17       Impact factor: 13.837

Review 8.  Ghrelin and food reward.

Authors:  Omar Al Massadi; Ruben Nogueiras; Carlos Dieguez; Jean-Antoine Girault
Journal:  Neuropharmacology       Date:  2019-01-05       Impact factor: 5.250

9.  Hepatic portal glucose infusions decrease food intake and increase food preference.

Authors:  M G Tordoff; M I Friedman
Journal:  Am J Physiol       Date:  1986-07

Review 10.  POMC neuronal heterogeneity in energy balance and beyond: an integrated view.

Authors:  Carmelo Quarta; Marc Claret; Lori M Zeltser; Kevin W Williams; Giles S H Yeo; Matthias H Tschöp; Sabrina Diano; Jens C Brüning; Daniela Cota
Journal:  Nat Metab       Date:  2021-02-25
View more
  1 in total

1.  Long-term hepatic and cardiac health in patients diagnosed with Sheehan's syndrome.

Authors:  Liza Das; Jayaprakash Sahoo; Neelam Dahiya; Sunil Taneja; Sanjay Kumar Bhadada; Mohammad Hayat Bhat; Paramjeet Singh; Vanita Suri; Bashir Ahmad Laway; Pinaki Dutta
Journal:  Pituitary       Date:  2022-10-15       Impact factor: 3.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.